Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q1 2020 · 10-Q
Revenue$20.00K$20.00K— vs Q1 2019 Net Income-$2.54M-$2.54MN/M vs Q1 2019 EPS Diluted-$0.01-$0.01N/M vs Q1 2019 Operating Income-$2,406,122N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
Margins · derivedOperating margin-12030.6%
Net margin-12714.9%
ended Mar 31, 2020 · filed May 11, 2020 · 41 d after period end